Table 1. Demographic and Clinical Characteristics of Pregnant Women Vaccinated With the BNT162b2 mRNA COVID-19 Vaccine.
| Characteristic | Women (N = 130)a |
|---|---|
| Maternal age, mean (SD), y | 31.9 (4.9) |
| Body mass index, median (IQR)b | 27.5 (24.9-30.0) |
| Background systemic diseasec | 30 (23.1) |
| Jewish religion | 119 (91.5) |
| Arab ethnicity | 11 (8.5) |
| Primipara | 61 (46.9) |
| Multipara (≥2 births) | 30 (23.1) |
| Grand multipara (≥5 births) | 2 (1.5) |
| Gestational age at first vaccine dose, mean (SD), wk | 21.9 (3.2) |
| Systemic adverse effects after first vaccine dosed | 13 (10) |
| Gestational age at second vaccine dose, mean (SD), wk | 24.9 (3.3) |
| Systemic adverse effectsd | |
| After second vaccine dose | 41 (31.5) |
| After first and/or second vaccine dose | 47 (36.2) |
| Gestational age at birth, mean (SD), wk | 39.3 (1.3) |
| Duration from second vaccine dose to birth, mean (SD), wk | 14.4 (3.0) |
| SARS-CoV-2 IgG antibody level, median (range), AU/mL | |
| Intrapartum maternal | 1185.2 (146.6-32 415.1) |
| Newborn | 3315.7 (350.1-17 643.5) |
| Newborn sex | |
| Male | 70 (53.8) |
| Female | 60 (46.2) |
| Newborn weight, mean (SD), g | 3265.2 (429.1) |
a
Data are presented as number (percentage) of women unless otherwise indicated.
b
Calculated as weight in kilograms divided by height in meters squared.
c
Hypertension (5 women), diabetes (7 women), asthma (4 women), thyroid disease (7 women), celiac (2 women), Crohn disease (1 woman), familial Mediterranean fever (1 woman), multiple sclerosis (2 women), and epidermolysis bullosa (1 woman).
d
General weakness, dizziness, fever, headache, general muscle aches, fatigue, and general rash.